Keywords: strong, ph, ii, data, genzyme/bayer, ms, drug

Strong Ph II data on Genzyme/Bayer's MS drug

Article | 14 May 2007

Print This

US biotechnology major Genzyme and German drugmaker Bayer Healthcare reported positive interim data from the CAMMS223 Phase II study of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in